A5090358214- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Bacterial Infections and Vaccines
- Influenza Virus Research Studies
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Vaccine Coverage and Hesitancy
- Pneumocystis jirovecii pneumonia detection and treatment
- Diabetes Treatment and Management
- Nosocomial Infections in ICU
- COVID-19 epidemiological studies
- Neonatal and Maternal Infections
- Clostridium difficile and Clostridium perfringens research
- Microscopic Colitis
- Virology and Viral Diseases
- SARS-CoV-2 detection and testing
- Emergency and Acute Care Studies
- Mosquito-borne diseases and control
- Animal Disease Management and Epidemiology
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- Inflammatory Bowel Disease
- Child and Adolescent Health
- Streptococcal Infections and Treatments
- Adolescent and Pediatric Healthcare
Pfizer (United States)
2022-2025
The University of Tokyo
2025
Boehringer Ingelheim (United States)
2020-2023
University of Bedfordshire
2023
Sanofi (United States)
2015-2021
University of Hong Kong
2018
GlaxoSmithKline (Belgium)
2017
University Hospitals of Leicester NHS Trust
2011-2014
Novartis (United States)
2009-2010
Centers for Disease Control and Prevention
2006-2008
Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants United States 2000, are responsible most penicillin-resistant infections. We examined effect this vaccine on invasive disease caused by resistant strains.
Pneumococcal disease is more frequent and deadly in persons with certain comorbidities. We used 1999 2000 data from the Active Bacterial Core surveillance (ABCs) National Health Interview Survey (NHIS) to determine rates of invasive pneumococcal healthy adults (> or =18 years old) various high-risk conditions. The risks specific chronic illnesses was compared that adults, controlling for age, race, other illnesses. Overall incidence rates, cases/100,000 persons, were 8.8 51.4 diabetes, 62.9...
Acute otitis media (AOM) is the most common cause of pediatric medical visits and antibiotic prescriptions worldwide, but its current impact on US healthcare system not clear. The aim this study was to investigate changes in incidence AOM from 2008, just before 13-valent pneumococcal conjugate vaccine introduced, 2014 using insurance records Truven MarketScan® database. also examined costs associated with index events during two recent years for which data were available (2013–2014). cases...
Pneumonia is the leading cause of morbidity and mortality worldwide. Pneumococcal conjugate vaccines have reduced burden pneumonia, but data on current pneumonia its impact healthcare system are needed to inform development use new other preventive measures.We retrospectively analyzed frequency in US during 2008-2014 using from MarketScan® Commercial Claims Encounters database. Frequencies utilization related index episode were calculated annual number enrolled person-years (PY) as...
High attack rates among vaccinated young adults reported during the 2006 mumps outbreak in United States heightened concerns regarding vaccine failure.
Despite several studies that have estimated the economic impact of Respiratory Syncytial Virus (RSV) in infants, limited data are available on healthcare resource use and costs attributable to RSV across age groups. The aim this study was quantify age-specific RSV-related US system.This retrospective case-control identified patients aged ≥1 year with an event Truven Health Marketscan® Commercial Claims Encounters Medicare Supplemental Coordination Benefits databases between August 31, 2012...
Abstract Introduction Flaviviruses such as dengue virus (DENV), Zika (ZIKV), Japanese encephalitis (JEV), and Yellow fever (YFV) are mosquito-borne RNA viruses causing major public health threats in parts of the world. While DENV ZIKV have been detected urine samples, data on presence stability flaviviruses water environment limited. Methods In this study, we determined infectivity flavivirus different environments by utilizing RT-qPCR plaque assay to explore feasibility environmental...
Abstract Background As SARS-CoV-2 evolves, assessing changes in COVID-19 severity over time, and the impact of prior infection on repeat infection, is important. We determined whether developing early pandemic was associated with reduced subsequent Omicron sub-lineages. Methods evaluated among patients infected during wave. Severity measured 3 ways:(1) an ordinal measure combining activities daily living (ADL) presence fever,(2) healthcare required (yes/no),(3) illness duration. compared...